Daix (France), New York City (New York, United States), January 24, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva” or the "Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH”) and other diseases with significant unmet medical needs, today announced the half-year report of its liquidity contract with Kepler Cheuvreux.
Under the liquidity contract granted to Kepler Cheuvreux by Inventiva, the following resources were available in the liquidity account as of 31 December 2024:
- Cash: € 349,630.55
- Number of shares: 113,452
- Number of executions on buy side on semester: 1,281
- Number of executions on sell side on semester: 1,366
- Trade volume on buy side on semester: 215,444 shares for € 477,452.69
- Traded volume on sell side on semester: 231,651 shares for € 538,913.35
- Cash: € 285,764.46
- Number of shares: 129,659
- Number of executions on buy side on semester: 1,886
- Number of executions on sell side on semester: 1,610
- Trade volume on buy side on semester: 322,578 shares for € 1,074,534.26
- Traded volume on sell side on semester: 276,147 shares for € 938,985.90
- Cash: € 163,510.42
- Number of shares: 34,063
|
| Buy Side |
| Sell Side | |||||||||||
|
| Number of executions | Number of shares | Traded volume in EUR |
| Number of executions | Number of shares | Traded volume in EUR | |||||||
| Total | 1,281 | 215,444 | 477,452.69 | 1,366 | 231,651 | 538,913.35 | ||||||||
| 07/01/2024 | 10 | 1,748 | 4,754.56 | 10 | 1,500 | 4,200.00 | ||||||||
| 07/02/2024 | 5 | 750 | 2,085.00 | 3 | 750 | 2,100.00 | ||||||||
| 07/03/2024 | 14 | 1,750 | 4,847.50 | 7 | 1,250 | 3,500.00 | ||||||||
| 07/04/2024 | 10 | 1,751 | 4,850.27 | 7 | 1,208 | 3,358.24 | ||||||||
| 07/05/2024 | 9 | 1,250 | 3,487.50 | 12 | 2,243 | 6,280.40 | ||||||||
| 07/08/2024 | 45 | 9,505 | 22,716.95 | 23 | 3,419 | 8,376.55 | ||||||||
| 07/09/2024 | 9 | 1,996 | 4,910.16 | 16 | 2,831 | 7,020.88 | ||||||||
| 07/10/2024 | 33 | 4,849 | 11,637.60 | 8 | 1,500 | 3,735.00 | ||||||||
| 07/11/2024 | 14 | 2,750 | 6,600.00 | 31 | 5,750 | 14,087.50 | ||||||||
| 07/12/2024 | 6 | 1,100 | 2,805.00 | 25 | 4,366 | 11,264.28 | ||||||||
| 07/15/2024 | 11 | 4,150 | 10,416.50 | 6 | 984 | 2,587.92 | ||||||||
| 07/16/2024 | 23 | 5,500 | 12,925.00 | 6 | 1,000 | 2,450.00 | ||||||||
| 07/17/2024 | 12 | 3,570 | 8,425.20 | 6 | 1,500 | 3,585.00 | ||||||||
| 07/18/2024 | 1 | 1 | 2.42 | 28 | 6,751 | 16,674.97 | ||||||||
| 07/19/2024 | - | - | - | 7 | 1,779 | 4,500.87 | ||||||||
| 07/22/2024 | 8 | 1,350 | 3,361.50 | 1 | 250 | 625.00 | ||||||||
| 07/23/2024 | 17 | 3,501 | 8,507.43 | 8 | 1,497 | 3,697.59 | ||||||||
| 07/24/2024 | 23 | 4,050 | 9,598.50 | 3 | 317 | 767.14 | ||||||||
| 07/25/2024 | 32 | 5,101 | 11,477.25 | 1 | 1 | 2.35 | ||||||||
| 07/26/2024 | 13 | 2,250 | 5,107.50 | 22 | 5,283 | 12,362.22 | ||||||||
| 07/29/2024 | 21 | 2,361 | 5,217.81 | - | - | - | ||||||||
| 07/30/2024 | 7 | 1,640 | 3,575.20 | 9 | 2,000 | 4,420.00 | ||||||||
| 07/31/2024 | 8 | 1,751 | 3,887.22 | 14 | 2,001 | 4,502.25 | ||||||||
| 08/01/2024 | 23 | 3,849 | 8,313.84 | 3 | 251 | 542.16 | ||||||||
| 08/02/2024 | 7 | 1,500 | 3,195.00 | 9 | 1,750 | 3,762.50 | ||||||||
| 08/05/2024 | 15 | 2,750 | 5,802.50 | 1 | 250 | 537.50 | ||||||||
| 08/06/2024 | 9 | 1,295 | 2,693.60 | 7 | 639 | 1,341.90 | ||||||||
| 08/07/2024 | 4 | 705 | 1,466.40 | 18 | 2,640 | 5,623.20 | ||||||||
| 08/08/2024 | 3 | 569 | 1,223.35 | 7 | 617 | 1,332.72 | ||||||||
| 08/09/2024 | 5 | 973 | 2,091.95 | 11 | 1,151 | 2,509.18 | ||||||||
| 08/12/2024 | 19 | 3,708 | 7,786.80 | - | - | - | ||||||||
| 08/13/2024 | 11 | 1,750 | 3,622.50 | 6 | 523 | 1,098.30 | ||||||||
| 08/14/2024 | 8 | 1,750 | 3,605.00 | 1 | 42 | 87.36 | ||||||||
| 08/15/2024 | 4 | 730 | 1,518.40 | 16 | 2,129 | 4,449.61 | ||||||||
| 08/16/2024 | 6 | 870 | 1,818.30 | 9 | 402 | 848.22 | ||||||||
| 08/19/2024 | 1 | 70 | 151.20 | 31 | 5,816 | 12,795.20 | ||||||||
| 08/20/2024 | 1 | 9 | 20.25 | 12 | 1,886 | 4,281.22 | ||||||||
| 08/21/2024 | 8 | 2,000 | 4,640.00 | 19 | 2,969 | 6,947.46 | ||||||||
| 08/22/2024 | 7 | 1,250 | 2,850.00 | - | - | - | ||||||||
| 08/23/2024 | 8 | 1,251 | 2,839.77 | 6 | 501 | 1,147.29 | ||||||||
| 08/26/2024 | 15 | 3,491 | 7,784.93 | 9 | 787 | 1,794.36 | ||||||||
| 08/27/2024 | 4 | 1,000 | 2,210.00 | 7 | 928 | 2,078.72 | ||||||||
| 08/28/2024 | 11 | 1,250 | 2,750.00 | 1 | 250 | 552.50 | ||||||||
| 08/29/2024 | 12 | 1,302 | 2,838.36 | 6 | 334 | 731.46 | ||||||||
| 08/30/2024 | 9 | 746
| ||||||||||||